Terms: = Breast cancer AND CNTRL, CEP1, CEP110, 11064, ENSG00000119397
5 results:
1. Centromere 17 copy number gain reflects chromosomal instability in breast cancer.
Lee K; Kim HJ; Jang MH; Lee S; Ahn S; Park SY
Sci Rep; 2019 Nov; 9(1):17968. PubMed ID: 31784614
[TBL] [Abstract] [Full Text] [Related]
2. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract] [Full Text] [Related]
3. A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients.
Pongor L; Kormos M; Hatzis C; Pusztai L; Szabó A; Győrffy B
Genome Med; 2015 Oct; 7():104. PubMed ID: 26474971
[TBL] [Abstract] [Full Text] [Related]
4. The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73.
Peschiaroli A; Scialpi F; Bernassola F; Pagano M; Melino G
Oncogene; 2009 Sep; 28(35):3157-66. PubMed ID: 19581926
[TBL] [Abstract] [Full Text] [Related]
5. The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells.
Kato M; Paranjape T; Müller RU; Nallur S; Gillespie E; Keane K; Esquela-Kerscher A; Weidhaas JB; Slack FJ
Oncogene; 2009 Jun; 28(25):2419-24. PubMed ID: 19421141
[TBL] [Abstract] [Full Text] [Related]
